Seliciclib (CAS 186692-46-6): A Potent CDK Inhibitor for Pharmaceutical Research
Discover Seliciclib, a leading CDK inhibitor crucial for advancing cell cycle research and drug discovery. As a key pharmaceutical intermediate, we provide high-purity Seliciclib to manufacturers and researchers worldwide. Explore our offerings and secure your supply.
Get a Quote & SampleHigh-Purity Seliciclib for Advanced Research Applications
Seliciclib (CAS 186692-46-6)
As a trusted manufacturer and supplier, we offer Seliciclib, a highly selective inhibitor of cyclin-dependent kinases (CDKs). This crucial pharmaceutical intermediate is essential for research into cell cycle regulation, apoptosis, and anti-angiogenic therapies. Rely on us for consistent quality and reliable supply from China.
- Discover the therapeutic potential of Seliciclib, a vital CDK inhibitor for drug discovery.
- Source high-purity Seliciclib (CAS 186692-46-6) from a leading Chinese manufacturer.
- Explore the applications of this API intermediate in cancer research and beyond.
- Get competitive pricing and prompt delivery for your research needs.
Advantages of Sourcing Seliciclib from Us
Uncompromising Quality and Purity
Our Seliciclib is manufactured to stringent standards, ensuring a purity of >98% (HPLC). This commitment guarantees reliable and reproducible results for your research, making us a preferred supplier for demanding applications.
Expertise as a Leading Manufacturer
Leverage our extensive experience as a Seliciclib manufacturer in China. We offer competitive prices and a stable supply chain, essential for procurement managers seeking cost-effective and dependable solutions for their R&D projects.
Comprehensive Support for Researchers
We provide essential technical data and product information to support your research. Whether you are exploring how to buy Seliciclib or seeking a reliable supplier, our team is dedicated to meeting your specific requirements.
Key Applications of Seliciclib
CDK Inhibition Studies
Seliciclib is a crucial tool for investigating the role of Cyclin-Dependent Kinases (CDKs) in cell proliferation and development, critical for understanding cancer biology.
Apoptosis Induction Research
Researchers utilize Seliciclib to study apoptosis pathways, offering insights into programmed cell death mechanisms vital for therapeutic development.
Anti-angiogenesis Research
As an anti-angiogenic agent, Seliciclib is valuable in studies focused on inhibiting new blood vessel formation, a key factor in tumor growth.
Pharmaceutical Intermediate
High-purity Seliciclib serves as a key intermediate in the synthesis of advanced pharmaceutical compounds, supporting the development of novel therapeutics.